- Home
- UCB vs VKTX Comparison
UCB vs VKTX Comparison
Compare UCB & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCB
- VKTX
- Stock Information
- Founded
- UCB 1950
- VKTX 2012
- Country
- UCB United States
- VKTX United States
- Employees
- UCB N/A
- VKTX N/A
- Industry
- UCB
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- UCB
- VKTX Health Care
- Exchange
- UCB NYSE
- VKTX Nasdaq
- Market Cap
- UCB 4.0B
- VKTX 4.6B
- IPO Year
- UCB 2002
- VKTX 2015
- Fundamental
- Price
- UCB $31.75
- VKTX $42.25
- Analyst Decision
- UCB Hold
- VKTX Strong Buy
- Analyst Count
- UCB 2
- VKTX 12
- Target Price
- UCB $29.00
- VKTX $106.75
- AVG Volume (30 Days)
- UCB 754.4K
- VKTX 3.8M
- Earning Date
- UCB 01-01-0001
- VKTX 02-05-2025
- Dividend Yield
- UCB 2.98%
- VKTX N/A
- EPS Growth
- UCB N/A
- VKTX N/A
- EPS
- UCB 1.53
- VKTX N/A
- Revenue
- UCB $827,444,000.00
- VKTX N/A
- Revenue This Year
- UCB N/A
- VKTX N/A
- Revenue Next Year
- UCB N/A
- VKTX N/A
- P/E Ratio
- UCB $20.62
- VKTX N/A
- Revenue Growth
- UCB N/A
- VKTX N/A
- 52 Week Low
- UCB $24.04
- VKTX $17.23
- 52 Week High
- UCB $35.38
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- UCB 39.91
- VKTX 33.93
- Support Level
- UCB $30.89
- VKTX $37.80
- Resistance Level
- UCB $33.34
- VKTX $48.55
- Average True Range (ATR)
- UCB 0.78
- VKTX 2.54
- MACD
- UCB -0.46
- VKTX -0.45
- Stochastic Oscillator
- UCB 14.33
- VKTX 30.11
About UCB UNITED COMMUNITY BANKS(GEORGIA)
United Community Banks Inc is a bank holding company that operates through its wholly-owned subsidiary, Union Community Bank. The bank has scores of offices throughout portions of Georgia, Tennessee, and the Carolinas. It has traditionally grown through the organic growth of existing offices and de novo locations, complemented by selective acquisitions. United conducts substantially all of its operations through a community-focused operating model of separate community banks. The community banks offer a full range of retail and corporate banking services, including checking, savings, and time deposit accounts, as well as secured and unsecured loans, wire transfers, brokerage services, and other financial services. The bank's loan portfolio is well-diversified but predominantly commercial.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.